Nerve Culture Offers New Tool For Scientists, Drug Companies

The successful growth of human brain cells in a dish already has some researchers pondering commercial applications WASHINGTON - When a team of neuroscientists at Johns Hopkins Medical School made headlines this past May for establishing a colony of human neurons that divide and grow in a petri dish, they may have launched a new era on the business side - as well as the science side - of neurobiology. The Johns Hopkins team, headed by Solomon Snyder, reported its achievement in the journal Sc

Written byJoe Dileo
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share


The successful growth of human brain cells in a dish already has some researchers pondering commercial applications
WASHINGTON - When a team of neuroscientists at Johns Hopkins Medical School made headlines this past May for establishing a colony of human neurons that divide and grow in a petri dish, they may have launched a new era on the business side - as well as the science side - of neurobiology.

The Johns Hopkins team, headed by Solomon Snyder, reported its achievement in the journal Science (248: 603, 1990). The advance, observers say, will allow researchers to better study the biochemistry and genetics of human brain tissue, since it allows them to manipulate cells over longer periods of time.

For investigators working in the field, the ability to grow neurons outside the body provides a powerful research tool. "It's a real leap forward," says Frederick Goodwin, head of the Alcohol, Drug ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies